The Use of Long-Acting Injectable Antipsychotics in Schizophrenia.
about
"Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research.Aripiprazole Lauroxil: A Review in Schizophrenia.Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
P2860
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia.
@en
type
label
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia.
@en
prefLabel
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia.
@en
P2860
P1476
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia.
@en
P2093
Seiya Miyamoto
W Wolfgang Fleischhacker
P2860
P2888
P304
P356
10.1007/S40501-017-0115-Z
P577
2017-04-19T00:00:00Z
P6179
1084936518